Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N G Guseva

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Revmatologiia (Moscow, Russia)|April 1, 1986
[Significance of microcirculatory disorders in various rheumatic diseases]N G Guseva
Terapevticheskii Arkhiv|January 1, 1992
[The clinical heterogeneity of the scleroderma group of diseases]N G Guseva
Revmatologiia (Moscow, Russia)|April 1, 1983
[Etiology and pathogenesis of systemic scleroderma]N G Guseva
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|February 13, 1999
[Forty years study of systemic scleroderma (data of Institute of Rheumatology, Russian Academy of Medical Sciences)]N G Guseva
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|December 10, 2008
[Overlap syndromes in rheumatology]N G Guseva
Klinicheskaia Meditsina|June 23, 2001
[Prostaglandin E1: results and perspectives in clinical practice]N G Guseva
Terapevticheskii Arkhiv|January 1, 1997
[The current strategy for pathogenetic therapy in systemic scleroderma]N G Guseva
Terapevticheskii Arkhiv|January 1, 1995
[The evolution of the concepts of systemic scleroderma]N G Guseva
Klinicheskaia Meditsina|March 1, 1992
[Multifocal fibrosis (localized systemic sclerosis)]N G Guseva
Meditsinskaia Sestra|July 1, 1970
[Systemic scleroderma]N G Guseva
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Revmatologiia (Moscow, Russia)|April 1, 1986
[Significance of microcirculatory disorders in various rheumatic diseases]N G Guseva
Terapevticheskii Arkhiv|January 1, 1992
[The clinical heterogeneity of the scleroderma group of diseases]N G Guseva
Revmatologiia (Moscow, Russia)|April 1, 1983
[Etiology and pathogenesis of systemic scleroderma]N G Guseva
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|February 13, 1999
[Forty years study of systemic scleroderma (data of Institute of Rheumatology, Russian Academy of Medical Sciences)]N G Guseva
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|December 10, 2008
[Overlap syndromes in rheumatology]N G Guseva
Klinicheskaia Meditsina|June 23, 2001
[Prostaglandin E1: results and perspectives in clinical practice]N G Guseva
Terapevticheskii Arkhiv|January 1, 1997
[The current strategy for pathogenetic therapy in systemic scleroderma]N G Guseva
Terapevticheskii Arkhiv|January 1, 1995
[The evolution of the concepts of systemic scleroderma]N G Guseva
Klinicheskaia Meditsina|March 1, 1992
[Multifocal fibrosis (localized systemic sclerosis)]N G Guseva
Meditsinskaia Sestra|July 1, 1970
[Systemic scleroderma]N G Guseva
Pageof 12